Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)
Sponsor: Hopital Foch
Terminated
Evolution of the treatment procedures so that their is no more benefits for patients
A NA clinical study on Lung Cancer, Non-small Cell, this trial is terminated or withdrawn. The trial is conducted by Hopital Foch and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2020 — Dec 2020 [monthly]
Recruiting NA
-
Sep 2019 — Mar 2020 [monthly]
Recruiting NA
-
Jul 2019 — Sep 2019 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hopital Foch
For direct contact, visit the study record on ClinicalTrials.gov .